Fibromyalgia News and Research

Latest Fibromyalgia News and Research

TONIX Pharmaceuticals announces Phase 2a study results of cyclobenzaprine in Fibromyalgia Syndrome

TONIX Pharmaceuticals (formerly known as Krele Pharmaceuticals), a specialty central nervous system (CNS) pharmaceutical company, announced results of a new analysis of a Phase 2a study, which previously demonstrated reduced pain, fatigue and tenderness in patients with Fibromyalgia Syndrome (FMS) following bedtime administration of very low dosage (VLD) cyclobenzaprine (CBP).

10 Nov 2010

Tai Chi benefits individuals with arthritis

In the largest study to date of the Arthritis Foundation's Tai Chi program, participants showed improvement in pain, fatigue, stiffness and sense of well-being.

8 Nov 2010

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain. Cymbalta was first used to treat major depressive disorder in 2004.

8 Nov 2010

Adeona receives $488,959 grants under QTDP program to support Alzheimer's, multiple sclerosis programs

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it was awarded two grants totaling $488,959 under the Qualifying Therapeutic Discovery Project (QTDP) Program to support the Company's Alzheimer's disease and multiple sclerosis programs currently in clinical testing.

4 Nov 2010

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Pfizer Inc announced that the Japanese Ministry of Health, Labour and Welfare approved Lyrica (pregabalin) capsules for the treatment of peripheral neuropathic pain. This follows the recent approval in Japan of Lyrica for the treatment of postherpetic neuralgia on April 16, 2010. Lyrica is the first medication approved for peripheral neuropathic pain in Japan where it is co-promoted with Eisai Co., Ltd.

29 Oct 2010

Forest Laboratories second quarter net sales increase 7.7% to $1,037.3 million

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $1.00 in the second quarter of fiscal 2011.

19 Oct 2010

Study suggests treating RLS may improve sleep and quality of life in people with fibromyalgia

A study in the Oct. 15, 2010 issue of the Journal of Clinical Sleep Medicine found that adults with fibromyalgia had a much higher prevalence and risk of restless legs syndrome than healthy controls. The study suggests that treating RLS may improve sleep and quality of life in people with fibromyalgia.

15 Oct 2010

Yoga exercises may combat fibromyalgia: Research

According to new research conducted at Oregon Health & Science University, yoga exercises may have the power to combat fibromyalgia a medical disorder characterized by chronic widespread pain. The research is being published in the November 10 online edition of the journal Pain and will appear online Thursday, Oct. 14.

14 Oct 2010

Yoga program improves fibromyalgia symptoms and functional deficits

Fibromyalgia (FM) is a debilitating condition affecting 11󈝻 million individuals in the US alone. FM carries an annual direct cost for care of more than $20 billion and drug therapies are generally only 30% effective in relieving symptoms and 20% effective in improving function. Standard care currently includes medications accompanied by exercise and coping skills approaches. In a study published in the November 2010 issue of PAIN, researchers report patients participating in a "Yoga of Awareness" program showed significantly greater improvement in FM symptoms and functioning compared to patients on a standard FM care program.

14 Oct 2010

FDA issues CRL to Jazz for JZP-6 NDA for fibromyalgia

Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has sent the company a complete response letter (CRL) regarding the company's New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia. The CRL states that the FDA cannot approve the NDA in its present form.

11 Oct 2010

Yoga, Tai Chi effective in treating fibromyalgia

This syndrome is often accompanied by fatigue, bowel disturbances, and urinary difficulty. Fibromyalgia can affect your daily activity, your sleep, and even your thinking when you're worn out and experiencing "brain fog." That's a term used by Henri Roca, MD, Medical Director at Greenwich Hospital's Center for Integrative Medicine in Cos Cob, Connecticut.

24 Sep 2010

Sensitizing effect of anger and sadness not limited to fibromyalgia patients

Researchers from Utrecht University who studied the effect of negative emotions on pain perception in women with and without fibromyalgia found that anger and sadness amplified pain equally in both groups. Full findings are now online and will publish in the October 2010 print issue of Arthritis Care & Research, a journal of the American College of Rheumatology.

24 Sep 2010

Communication breakdown exists between people with chronic pain, health care providers: Survey

Conversations with health care providers can be challenging at times for all patients, but a new survey commissioned by HealthyWomen and conducted by Synovate Healthcare in July of 2010 reveals a concerning communications breakdown between people with chronic pain and their health care providers. More than one-third of chronic pain sufferers (36%) have simply learned to live with their often debilitating pain and may be reluctant to speak with a health care provider about their condition, according to a survey of women and men with chronic pain released today.

22 Sep 2010

Chelsea Therapeutics' Phase III NORTHERA Study 301 meets primary endpoint

Chelsea Therapeutics International, Ltd. announced that preliminary analyses of its Phase III NORTHERA™ Study 301 met its primary endpoint. Treatment with Northera provided clinically meaningful and statistically significant improvement.

20 Sep 2010

Physically active adolescents with fibromyalgia report lower levels of pain, disability: Study

Adolescents with fibromyalgia who are physically active report lower levels of pain and disability, according to findings of a multicenter study published in The Journal of Pain, published by the American Pain Society, ampainsoc.org.

16 Sep 2010

FDA-cleared LaserTouchOne device for chronic and acute pain treatment available without prescription

The American Pain Foundation reports that despite the fact that the majority of the U.S. population looks healthy, statistics tell a different story: Approximately 1 in 3 Americans suffer from chronic pain. This chronic pain could be related to an illness like cancer or rheumatoid arthritis, or a condition such as arthritis, migraine headaches, fibromyalgia or back pain from a car accident.

15 Sep 2010

Latest achievements in brain research and treatment for mental disorders

Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.

30 Aug 2010

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

26 Aug 2010

Vitamin D2 in AbM mushroom can neutralize oxidative stress: Research

Total Nutraceutical Solutions, Inc., announced that it has completed a research study comparing the therapeutic effect of single nutrient forms of synthetic Vitamin D3 and D2 versus natural Vitamin D2 within a whole food. The study focused on the control of Paraquat induced oxidative stress/biologic death.

25 Aug 2010

National Fibromyalgia Association, RemedyMD partner to build fibromyalgia research registry

The National Fibromyalgia Association has partnered with RemedyMD® to provide a national database that will aggregate data from a wide variety of sources to provide a complete disease registry for fibromyalgia research. It offers new hope to sufferers since this will represent the first time that researchers have the opportunity to look at all data relevant to fibromyalgia in order to identify patterns which lead to more effective diagnosis and treatment.

24 Aug 2010

Fibromyalgia News and Research

Latest Fibromyalgia News and Research

TONIX Pharmaceuticals announces Phase 2a study results of cyclobenzaprine in Fibromyalgia Syndrome

Tai Chi benefits individuals with arthritis

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

Adeona receives $488,959 grants under QTDP program to support Alzheimer's, multiple sclerosis programs

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Forest Laboratories second quarter net sales increase 7.7% to $1,037.3 million

Study suggests treating RLS may improve sleep and quality of life in people with fibromyalgia

Yoga exercises may combat fibromyalgia: Research

Yoga program improves fibromyalgia symptoms and functional deficits

FDA issues CRL to Jazz for JZP-6 NDA for fibromyalgia

Yoga, Tai Chi effective in treating fibromyalgia

Sensitizing effect of anger and sadness not limited to fibromyalgia patients

Communication breakdown exists between people with chronic pain, health care providers: Survey

Chelsea Therapeutics' Phase III NORTHERA Study 301 meets primary endpoint

Physically active adolescents with fibromyalgia report lower levels of pain, disability: Study

FDA-cleared LaserTouchOne device for chronic and acute pain treatment available without prescription

Latest achievements in brain research and treatment for mental disorders

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

Vitamin D2 in AbM mushroom can neutralize oxidative stress: Research

National Fibromyalgia Association, RemedyMD partner to build fibromyalgia research registry

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Fibromyalgia News and Research

Latest Fibromyalgia News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in